E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research.
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 15, 2022 | Series A | ¥100M | 4 | Momentum Venture | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Momentum Venture | Yes | Series A |
TaiKun Fund | — | Series A |
Hangzhou Jintou Industrial Fund | — | Series A |
LPSCO | — | Series A |